Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Healthcare Medical Devices
Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Therma Bright Inc > Analyses
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Comment by hk1966on May 31, 2022 10:20pm
183 Views
Post# 34722044

RE:RE:RE:RE:RE:RE:RE:RE:RE:Analyses

RE:RE:RE:RE:RE:RE:RE:RE:RE:AnalysesQuick math based on assumption each Venowave is around 400 retai. Assume sellout price per unit of $200 to DME and purchase cost landed of $100 should get you in the ballpark. Scale from there.2500 units sold as a pair should get 2500x2x100 in gross margin or $500 k in gross margin.I am confident that in the fall they will scale up sales to DMEas the market size in the US alone is potentially 2-10 million units per year based on a rapidly aging population 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities